AG
ISEE

Advisor Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Advisor Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-23
Closed – – 5417
2019
Q1 		$0 Sell
23
-4
-15% -$6 ﹤0.01% 5376
2018
Q4 		$0 Sell
27
-425
-94% -$824 ﹤0.01% 5291
2018
Q3 		$1K Buy
452
+291
+181% +$725 ﹤0.01% 5025
2018
Q2 		$0 Hold
161
– – ﹤0.01% 5088
2018
Q1 		$0 Buy
161
+2
+1% +$6 ﹤0.01% 5104
2017
Q4 		$0 Hold
159
– – ﹤0.01% 5102
2017
Q3 		$0 Hold
159
– – ﹤0.01% 4986
2017
Q2 		$0 Sell
159
-79
-33% -$215 ﹤0.01% 4944
2017
Q1 		$0 Sell
238
-133
-36% -$562 ﹤0.01% 4836
2016
Q4 		$2K Sell
371
-353
-49% -$10.5K ﹤0.01% 4265
2016
Q3 		$33K Buy
724
+69
+11% +$3.89K ﹤0.01% 2835
2016
Q2 		$31K Buy
+655
New +$32.5K ﹤0.01% 2772

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Advisor Group's ISEE Position: Q2 2019 in Review

Advisor Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2019, closing a stake of 23 shares.

Advisor Group first reported a position in ISEE in Q2 2016 and held it in 12 quarters. The position peaked at $33K in Q3 2016. 52 funds tracked by Wall St. Rank hold ISEE as of Q2 2019.

  • Advisor Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Advisor Group sold 23 IVERIC bio, Inc. Common Stock shares in Q2 2019.
  • Advisor Group first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 12 quarters.
  • Advisor Group's IVERIC bio, Inc. Common Stock position peaked at $33K in Q3 2016.
  • 52 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2019.

Based on Advisor Group's 13F filing for Q2 2019, filed 31 Jul 2019.